Celldex Therapeutics reported $2.29B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Agenus USD 107M 16M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.11B 307M Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Northwest Biotherapeutics USD 270M 86M Jun/2026
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025